Home / Current Issue / Paper 1719692
Toward an Integrated Conceptual Framework for Traceability and Chain-of-Custody Integrity in Pharmaceutical Distribution
Subject area: Biological & Medical Sciences · Area of research: Pharmaceutical Supply Chain
DOI: https://doi.org/10.64388/IREV3I4-1719692
Abstract
Modern pharmaceutical distribution moves medicines through long, multi-actor networks in which identity, provenance, custody, and condition can each be compromised. Regulatory and technical responses have advanced quickly, including serialization mandates, data exchange standards, good distribution practice guidance, and a growing body of work on distributed ledger and sensing technologies, yet they remain fragmented. Most concentrate on traceability, the technical capacity to follow a product through the chain, while the assurance that every custody transfer was authentic, authorized, and unbroken, here termed chain-of-custody integrity, is left implicit or treated as a separate concern. This paper argues that traceability and chain-of-custody integrity are distinct but interdependent constructs, and that integrity assurance requires their deliberate integration rather than the accumulation of point solutions. Drawing on supply chain traceability theory, the forensic conception of custody, and the contemporary regulatory and technical landscape, it proposes an integrated conceptual framework built on four integrity dimensions, namely identity, provenance, custody continuity, and condition, and a five-layer architecture spanning unique identification, event capture and data exchange, custody verification and authentication, condition and environmental integrity, and governance, trust, and accountability. Cross-cutting enablers of interoperability, security, and trust anchoring connect the layers, and the lower layers are shown to deliver traceability while the upper layers convert it into assurance. The framework is applied to a stylized distribution scenario to demonstrate how it locates integrity gaps that traceability-centric approaches leave hidden, and a set of propositions translates it into testable relationships. The framework offers regulators, supply chain actors, and technology providers a structured vocabulary for diagnosing where integrity is genuinely at risk and for designing systems in which traceability and custody assurance reinforce one another.
Keywords
Pharmaceutical Distribution, Traceability, Chain of Custody; Supply Chain Integrity, Serialization, Provenance, Conceptual Framework
References
[1] Agbabiaka, J., Okonkwo, C. S., Ogunwole, O., Mayo, W., & Okeke, O. T. (2019). Supply chain risk management model for EPC and gas processing projects. Iconic Research and Engineering Journals, 3(2), 968-980. https://doi.org/10.64388/IREV3I2-1713124
[2] Akomolafe, O., & Agu, M. U. (2018). A conceptual model for enhancing internal audit quality through technology-enabled risk assessment frameworks. Iconic Research and Engineering Journals, 1(9), 458-475.
[3] Akomolafe, O., & Agu, M. U. (2019a). A conceptual framework for developing risk-based internal control models in the insurance and banking sectors. Iconic Research and Engineering Journals, 2(8), 335-354.
[4] Akomolafe, O., & Agu, M. U. (2019b). A review of data-driven risk evaluation models for emerging market financial institutions. Iconic Research and Engineering Journals, 3(6), 433-448.
[5] Akomolafe, O., & Agu, M. U. (2019c). Advances in financial resilience through integrated governance and compliance strategies. Iconic Research and Engineering Journals, 2(10), 607-620.
[6] Aminu-Ibrahim, A. Y., Ogbete, J. C., & Ambali, K. B. (2018). Developing sustainable diagnostic laboratory infrastructure models for emerging and resource constrained health systems. Iconic Research and Engineering Journals, 1(8), 118-132. https://doi.org/10.64388/IREV1I8-1713586
[7] Aminu-Ibrahim, A. Y., Ogbete, J. C., & Ambali, K. B. (2019). Capital project delivery models for high risk healthcare infrastructure in developing national health systems. Iconic Research and Engineering Journals, 2(10), 626-649. https://doi.org/10.64388/IREV2I10-1713588
[8] Arumosoye, O. M., & Obriki, O. D. (2018). Development of an integrated heat stress risk conceptual model for industrial operations in extreme environments. Iconic Research and Engineering Journals, 1(12), 141-160. https://doi.org/10.64388/IREV1I12-1714415
[9] Arumosoye, O. M., & Obriki, O. D. (2019). Systematic review of near-miss and hazard observation data utilization in industrial safety management. Iconic Research and Engineering Journals, 3(2), 981-999. https://doi.org/10.64388/IREV3I2-1714417
[10] Blackstone, E. A., Fuhr, J. P., & Pociask, S. (2014). The health and economic effects of counterfeit drugs. American Health & Drug Benefits, 7(4), 216-224.
[11] Bocek, T., Rodrigues, B. B., Strasser, T., & Stiller, B. (2017). Blockchains everywhere: A use-case of blockchains in the pharma supply chain. In 2017 IFIP/IEEE Symposium on Integrated Network and Service Management (IM) (pp. 772-777). IEEE.
[12] Brechtelsbauer, E. D., Pennell, B., Durham, M., Hertig, J. B., & Weber, R. J. (2016). Review of the 2015 Drug Supply Chain Security Act. Hospital Pharmacy, 51(6), 493-500.
[13] Clauson, K. A., Breeden, E. A., Davidson, C., & Mackey, T. K. (2018). Leveraging blockchain technology to enhance supply chain management in healthcare: An exploration of challenges and opportunities in the health supply chain. Blockchain in Healthcare Today, 1.
[14] Commission Delegated Regulation (EU) 2016/161 of 2 October 2015 supplementing Directive 2001/83/EC of the European Parliament and of the Council by laying down detailed rules for the safety features appearing on the packaging of medicinal products for human use. (2016). Official Journal of the European Union, L 32, 1-27.
[15] Dagodzo, D. (2018a). A conceptual framework for UAV integration into national power grid inspection programs. Iconic Research and Engineering Journals, 2(5), 391-412. https://doi.org/10.64388/IREV2I5-1716082
[16] Dagodzo, D. (2018b). A review of UAV applications in electrical transmission line inspection: Methods, technologies, and challenges. Iconic Research and Engineering Journals, 2(6), 234-254. https://doi.org/10.64388/IREV2I6-1716083
[17] Dogbatsey, E. A., & Ebhojie, O. (2018). Budget compliance and statutory reporting in Sub-Saharan Africa: A systematic review of frameworks, gaps, and reform pathways. Zenodo. https://doi.org/10.5281/zenodo.20446859
[18] Dogbatsey, E. A., Ebhojie, O., & Oyeleye, A. O. (2019). Reconciliation control and financial workflow redesign in emerging market organizations: A conceptual framework. Zenodo. https://doi.org/10.5281/zenodo.20447103
[19] Dosunmu, A. A., & Ogundele, P. O. (2019). Security audit and enterprise risk assessment frameworks for resilient information systems. Iconic Research and Engineering Journals, 3(5), 434-447. https://doi.org/10.64388/IREV3I5-1713225
[20] European Parliament and Council. (2011). Directive 2011/62/EU amending Directive 2001/83/EC on the Community code relating to medicinal products for human use, as regards the prevention of the entry into the legal supply chain of falsified medicinal products. Official Journal of the European Union, L 174, 74-87.
[21] GS1. (2016). EPCIS standard (Version 1.2). GS1 AISBL.
[22] GS1. (2018). GS1 general specifications. GS1 AISBL.
[23] Institute of Medicine. (2013). Countering the problem of falsified and substandard drugs (G. J. Buckley & L. O. Gostin, Eds.). National Academies Press.
[24] International Organization for Standardization. (2007). Security management systems for the supply chain (ISO 28000:2007). ISO.
[25] Karlsen, K. M., Dreyer, B., Olsen, P., & Elvevoll, E. O. (2013). Literature review: Does a common theoretical framework to implement food traceability exist? Food Control, 32(2), 409-417.
[26] Ladapo, O. O., Dosunmu, A. A., Jooda, D., & Abolaji, T. O. (2018). Lessons learned from offline assessment of security-critical systems: The case of Microsoft Active Directory. Iconic Research and Engineering Journals, 2(6), 277-299. https://doi.org/10.64388/IREV2I6-1717205
[27] Ladapo, O. O., Jooda, D., Dosunmu, A. A., & Abolaji, T. O. (2019). Implementation of Active Directory for efficient management of enterprise networks. Iconic Research and Engineering Journals, 3(4), 608-627. https://doi.org/10.64388/IREV3I4-1717206
[28] Mackey, T. K., & Liang, B. A. (2011). The global counterfeit drug trade: Patient safety and public health risks. Journal of Pharmaceutical Sciences, 100(11), 4571-4579.
[29] Mackey, T. K., Liang, B. A., York, P., & Kubic, T. (2015). Counterfeit drug penetration into global legitimate medicine supply chains: A global assessment. The American Journal of Tropical Medicine and Hygiene, 92(6 Suppl), 59-67.
[30] Mackey, T. K., & Nayyar, G. (2017). A review of existing and emerging digital technologies to combat the global trade in fake medicines. Expert Opinion on Drug Safety, 16(5), 587-602.
[31] Mbonu, I. S., Aliliele, C., Iwuanyanwu, U., & Oluoha, O. M. (2018). A conceptual framework for legal and ethical risk modeling in enterprise data protection governance systems. Iconic Research and Engineering Journals, 2(2), 207-226. https://doi.org/10.64388/IREV2I2-1714911
[32] Mbonu, I. S., Aliliele, C., Uzoka, E., & Oluoha, O. M. (2019a). A review of comparative data protection regulations and secure cloud implementation strategies across jurisdictions. Iconic Research and Engineering Journals, 2(9), 482-501. https://doi.org/10.64388/IREV2I9-1714912
[33] Mbonu, I. S., Iwuanyanwu, U., Uzoka, E., & Oluoha, O. M. (2019b). Advances in enterprise log analytics and automated incident response architectures using Python and SIEM platforms. Iconic Research and Engineering Journals, 3(2), 1000-1019. https://doi.org/10.64388/IREV3I2-1714915
[34] Moe, T. (1998). Perspectives on traceability in food manufacture. Trends in Food Science & Technology, 9(5), 211-214.
[35] Obogo, S. F., Ozobu, C. O., & Uduokhai, D. O. (2019a). Advances in leadership driven safety culture transformation in large construction workforces. Iconic Research and Engineering Journals, 3(5), 507-523. https://doi.org/10.64388/IREV3I5-1715497
[36] Obogo, S. F., Ozobu, C. O., & Uduokhai, D. O. (2019b). Development of a construction safety risk governance model for multi contractor high rise projects. Iconic Research and Engineering Journals, 2(9), 502-522. https://doi.org/10.64388/IREV2I9-1715495
[37] Obogo, S. F., Uduokhai, D. O., & Ozobu, C. O. (2019c). Systematic review of hazard identification and risk control practices in urban construction projects. Iconic Research and Engineering Journals, 2(12), 666-681. https://doi.org/10.64388/IREV2I12-1715496
[38] Obriki, O. D., & Arumosoye, O. M. (2018). Conceptual modeling of data-driven occupational safety risk control in large-scale energy infrastructure projects. Iconic Research and Engineering Journals, 1(7), 169-189. https://doi.org/10.64388/IREV1I7-1714414
[39] Obriki, O. D., & Arumosoye, O. M. (2019). A conceptual framework linking management safety walkthrough frequency and coverage to safety culture outcomes in mega projects. Iconic Research and Engineering Journals, 2(8), 355-374. https://doi.org/10.64388/IREV2I8-1714416
[40] Ogbete, J. C., Aminu-Ibrahim, A. Y., & Ambali, K. B. (2018). Optimizing laboratory spatial planning strategies to improve diagnostic accuracy, safety, and clinical throughput. Iconic Research and Engineering Journals, 2(1), 87-113. https://doi.org/10.64388/IREV1I7-1713587
[41] Ogbete, J. C., Aminu-Ibrahim, A. Y., & Ambali, K. B. (2019). Regulatory compliant design systems for molecular and pathology laboratories in highly controlled environments. Iconic Research and Engineering Journals, 3(4), 607-631. https://doi.org/10.64388/IREV3I4-1713589
[42] Okonkwo, C. S., Ogunwole, O., & Okeke, O. T. (2018a). Framework for strategic procurement optimization in oil and gas operations. Iconic Research and Engineering Journals, 1(7), 153-168. https://doi.org/10.64388/IREV1I7-1713119
[43] Okonkwo, C. S., Ogunwole, O., & Okeke, O. T. (2018b). Model for inventory availability and plant uptime improvement in energy facilities. Iconic Research and Engineering Journals, 2(4), 160-172. https://doi.org/10.64388/IREV2I4-1713120
[44] Okonkwo, C. S., Ogunwole, O., Okeke, O. T., & Mayo, W. (2019). Conceptual framework for cost reduction through contract negotiation and vendor governance. Iconic Research and Engineering Journals, 2(9), 468-482. https://doi.org/10.64388/IREV2I9-1713121
[45] Olsen, P., & Borit, M. (2013). How to define traceability. Trends in Food Science & Technology, 29(2), 142-150.
[46] Sunday, E. A., Omoegun, G. O., Essien, M. A., & Oluokun, O. A. (2019). Thermodynamic efficiency and control strategies in residential air conditioning systems. International Journal of Scientific Research in Civil Engineering, 3(3), 52-76.
[47] Toyoda, K., Mathiopoulos, P. T., Sasase, I., & Ohtsuki, T. (2017). A novel blockchain-based product ownership management system (POMS) for anti-counterfeits in the post supply chain. IEEE Access, 5, 17465-17477.
[48] U.S. Congress. (1987). Prescription Drug Marketing Act of 1987, Pub. L. No. 100-293, 102 Stat. 95.
[49] U.S. Congress. (2013). Drug Quality and Security Act, Pub. L. No. 113-54, 127 Stat. 587 (Title II, Drug Supply Chain Security Act).
[50] World Health Organization. (2010). WHO good distribution practices for pharmaceutical products (WHO Technical Report Series No. 957, Annex 5). World Health Organization.
[51] World Health Organization. (2011). Model guidance for the storage and transport of time- and temperature-sensitive pharmaceutical products (WHO Technical Report Series No. 961, Annex 9). World Health Organization.
[52] World Health Organization. (2017a). A study on the public health and socioeconomic impact of substandard and falsified medical products. World Health Organization.
[53] World Health Organization. (2017b). WHO global surveillance and monitoring system for substandard and falsified medical products. World Health Organization.
How to cite this paper
@article{1719692,
author = {Oluchi Beatrice Aneke, Abimbola Caleb Adesemoye},
title = {Toward an Integrated Conceptual Framework for Traceability and Chain-of-Custody Integrity in Pharmaceutical Distribution},
journal = {Iconic Research And Engineering Journals},
year = {2019},
volume = {3},
number = {4},
pages = {655-672},
issn = {2456-8880},
url = {https://www.irejournals.com/formatedpaper/1719692.pdf},
abstract = {Modern pharmaceutical distribution moves medicines through long, multi-actor networks in which identity, provenance, custody, and condition can each be compromised. Regulatory and technical responses have advanced quickly, including serialization mandates, data exchange standards, good distribution practice guidance, and a growing body of work on distributed ledger and sensing technologies, yet they remain fragmented. Most concentrate on traceability, the technical capacity to follow a product through the chain, while the assurance that every custody transfer was authentic, authorized, and unbroken, here termed chain-of-custody integrity, is left implicit or treated as a separate concern. This paper argues that traceability and chain-of-custody integrity are distinct but interdependent constructs, and that integrity assurance requires their deliberate integration rather than the accumulation of point solutions. Drawing on supply chain traceability theory, the forensic conception of custody, and the contemporary regulatory and technical landscape, it proposes an integrated conceptual framework built on four integrity dimensions, namely identity, provenance, custody continuity, and condition, and a five-layer architecture spanning unique identification, event capture and data exchange, custody verification and authentication, condition and environmental integrity, and governance, trust, and accountability. Cross-cutting enablers of interoperability, security, and trust anchoring connect the layers, and the lower layers are shown to deliver traceability while the upper layers convert it into assurance. The framework is applied to a stylized distribution scenario to demonstrate how it locates integrity gaps that traceability-centric approaches leave hidden, and a set of propositions translates it into testable relationships. The framework offers regulators, supply chain actors, and technology providers a structured vocabulary for diagnosing where integrity is genuinely at risk and for designing systems in which traceability and custody assurance reinforce one another.},
keywords = {Pharmaceutical Distribution, Traceability, Chain of Custody; Supply Chain Integrity, Serialization, Provenance, Conceptual Framework},
month = {October},
doi = {https://doi.org/10.64388/IREV3I4-1719692}
}